A team from the Broad Institute at MIT and Harvard have designed a Cas13–CRISPR construct, termed CARVER, that can detect and kill viruses inside human cells. The flexible CARVER system could be used as a new tool in research and the clinic.
Browsing: Disease Area > Viral
Rotavirus infection can result in severe-life threatening illness in some individuals, however, new research from a team at Georgia State University (GA, USA), has identified bacteria that could be used to prevent or cure this infection.
Research presented at IDWeek has discovered that users of the social networking app, Grindr, took more risks and had more partners but were more likely to use, or be open to using, PrEP compared with those who didn’t use the app.
Two analyses supported by the Centers for Disease Control and Prevention’s US influenza data have demonstrated that immunization reduces the risk of hospitalization in children and death in adults
Take a look behind the scenes of a recent Future Virology editorial, entitled ‘The emerging field of endogenous retroviruses: understanding their physiological role and contribution to diseases’ as we ask author Enzo Tramontano (Università degli studi di Cagliari, Italy) about human endogenous retroviruses, whether they could be linked with disease and the future of this field.
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
Researchers have discovered that successful enterovirus infection could depend on the presence of a single protein in the host. Temporarily disabling this single protein could protect humans from the common cold and other viral diseases.
What impact will climate change have on vector-borne diseases? Discover more about rapid environmental and climate changes and the the distribution of vector-borne diseases in future.
Researchers have developed an animal model mimicking HIV infection in infants, potentially allowing the development of therapeutics and interventions for the pediatric population.
The results of a new study suggest that – compared with the general population – Ebola survivors may be at a significantly increased risk of death, particularly during the first year following hospital discharge.